This podcast is adapted from a news release "Positive Topline Results from Second Phase 3 Trial of First OSA Pill" Apnimed's successful outcomes AD109, an oral drug candidate designed to treat Obstructive Sleep Apnea (OSA). Results from the LunAIRo and SynAIRgy Phase 3 clinical trials demonstrate the drug's effectiveness in reducing airway obstruction and improving oxygenation in patients with mild, moderate, and severe OSA. You can read the full article here: https://sleepworldmagazine.com/2025/07/23/positive-topline…f-first-osa-pill/Start a free subscription to SleepWorld Magazine: https://hubs.li/Q03gs4dg0Check out more sleep-related podcasts here: https://sleepworldpodcastnetwork.com/

Ver todos los episodios